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Abstract
Background: Transgenerational epigenetics (TGE) are currently considered important in disease, but the
mechanisms involved are not yet fully understood. TGE abnormalities expected to cause disease are likely to be
initiated during development and to be mediated by aberrant gene expression associated with aberrant promoter
methylation that is heritable between generations. However, because methylation is removed and then re-
established during development, it is not easy to identify promoter methylation abnormalities by comparing
normal lineages with those expected to exhibit TGE abnormalities.
Methods: This study applied the recently proposed principal component analysis (PCA)-based unsupervised feature
extraction to previously reported and publically available gene expression/promoter methylation profiles of rat primordial
germ cells, between E13 and E16 of the F3 generation vinclozolin lineage that are expected to exhibit TGE abnormalities,
to identify multiple genes that exhibited aberrant gene expression/promoter methylation during development.
Results: The biological feasibility of the identified genes were tested via enrichment analyses of various biological
concepts including pathway analysis, gene ontology terms and protein-protein interactions. All validations
suggested superiority of the proposed method over three conventional and popular supervised methods that
employed t test, limma and significance analysis of microarrays, respectively. The identified genes were globally
related to tumors, the prostate, kidney, testis and the immune system and were previously reported to be related
to various diseases caused by TGE.
Conclusions: Among the genes reported by PCA-based unsupervised feature extraction, we propose that
chemokine signaling pathways and leucine rich repeat proteins are key factors that initiate transgenerational
epigenetic-mediated diseases, because multiple genes included in these two categories were identified in this study.
Background
Transgenerational epigenetics (TGE) [1] describes the
transfer of phenotypes between generations without the
modification of genome sequences. Because the plant
germline arises from somatic cells, TGE is often observed
in plants. However, TGE was also reported in the off-
spring of mammals, when pregnant females are exposed
to endocrine disruptions. Many factors are affected by
TGE including male infertility [2], anxious behavior [3],
mate preference [4], various diseases [5], reprogramming
of primordial germ cells [6], and stress responses [7].
In contrast to reports studying the relationship of
TGE to various abnormalities, few studies have investi-
gated how TGE occurs. The main difficulty of studying
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TGE mechanisms is that epigenetic markers such as
promoter methylation are not only heritable, but also
vary over time during development in the generation
associated with TGE. For example, for promoter methy-
lation to affect development, it must be switched on/off
during various stages of development [1]. Thus, TGE
that affects development is expected to follow a similar
time course. Therefore, abnormalities caused by TGE
must be related to the aberrant timing of promoter
methylation/demethylation when compared with normal
organisms. Detecting small irregularities of promoter
methylation timing based on comparisons with normal
organisms is not easy. For example, Skinner et al [6]
recently tried to identify aberrant gene expression asso-
ciated with aberrant promoter methylation between E13
and E16 germ line in F3 generation vinclozolin lineages,
where vinclozolin functions as an endocrine disruptor.
Endocrine disruption is thought to cause various dis-
eases especially in reproductive organs, because it is
often misrecognized as a hormone effect on the develop-
ment of reproductive organs. Thus, usage of endocrine
disruptors is usually forbidden for public health. Further-
more, vinclozolin was recently observed to cause TGE
abnormalities. However, Skinner et al failed to identify
strict pairs of aberrant gene expression and promoter
methylation for specific genes. They concluded “A com-
parison between the germ cell DMR (differential DNA
methylated regions) and the differentially expressed
genes indicated no significant overlap”. Thus, our under-
standing of the mechanisms by which TGE occurs
remains poor.
In the present study we applied the recently proposed
principal component analysis (PCA)-based unsupervised
feature extraction (FE) [8-17] to the data set obtained by
Skinner et al [6] and successfully identified a significant
overlap between DMR and differentially expressed
genes. Various methods for enrichment analyses sup-
ported the biological feasibility of the 48 identified
RefSeq mRNAs. We also confirmed the superiority of
the proposed methodology over three other methods.
The relatively poorer performances achieved by these
three methodologies compared with PCA-based unsu-
pervised FE indicated that the proposed methodology
outperformed these three frequently employed methods.
Furthermore, 22 genes among those derived from the
48 RefSeq mRNAs identified by PCA-based unsupervised
FE were previously reported to be related to diseases
caused by TGE [5]. This suggests that aberrant gene
expression associated with aberrant promoter methyla-
tion during this stage of development is a key factor in
the generation of TGE-mediated diseases. Because multi-
ple genes involved in chemokine signaling pathways
or containing leucine-rich repeat (LRR) proteins were
identified in the current study, we hypothesized that
chemokine signaling pathways and/or LRR proteins were
involved in mediating TGE-related diseases.
Previous usage of PCA-based unsupervised FE
Here, we briefly review previous studies [8-17] that used
PCA-based unsupervised FE. In Refs. [8-11], we applied
PCA-based unsupervised FE to microRNA expression
for biomarker identification between patients (of various
diseases including various cancers, chronic obstructive
pulmonary disease, and Alzheimer’s disease, etc) and
healthy controls; microRNA extracted in an unsuper-
vised manner was combined with linear discriminant
analysis. We found a combination of 10-20 microRNAs
generally achieved about 80 % accuracy. It was also con-
firmed that the identified set of microRNAs were stable.
Thus, this method is robust for the selection of samples.
In Ref. [12], we applied PCA-based unsupervised FE to
the proteome in a bacterial culture and identified critical
proteins in an unsupervised manner. In Ref. [13], we
applied PCA-based unsupervised FE to mRNA and
miRNA expression of stressed mouse heart. After identi-
fying potential disease causing genes, we performed in
silico drug discovery of the identified genes. In Ref. [14],
we performed integrated analysis of promoter methyla-
tion profiles of three distinct autoimmune diseases using
PCA-based unsupervised FE and identified many genes
commonly associated with aberrant promoter methyla-
tion. In Ref. [15], we applied PCA-based unsupervised
FE to genotyping/DNA methylation profiles of cancer
and identified genotype specific DNA methylation pro-
files that occurred in cancer genetics. In Refs [16,17],
PCA-based unsupervised FE of mRNA expression and
promoter methylation profiles of normal/treated cancer
cell lines was investigated. Based upon the integrated
analysis of mRNA expression and promoter methylation
profiles, we identified potential disease causing genes.
In summary, PCA-based unsupervised FE has mainly
been used to compare between patients (or cancer cell
lines) and healthy controls excluding one exception [12].
Because it is likely that healthy controls and patients (or
control and treated cancer cell lines) exhibit distinct
expressions, it is not surprising that PCA-based unsu-
pervised FE detected significant differences, even if most
of the biomarker/disease causing genes were identified
only by PCA-based unsupervised FE, but not by other
methodologies. In this study, we applied PCA-based
unsupervised FE to a different factor, the difference
between two time points (E13 and E16). These time
points represent different developmental stages and thus
some differences are expected; however, the time points
are separated by only 3 days, and therefore the differ-
ences should be much smaller than between healthy
controls and patients (or control and treated cancer cell
lines). Of note, although Skinner et al [6] reported no
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aberrant gene expression associated with aberrant pro-
moter methylation between E13 and E16 germ lines in
F3 generation vinclozolin lineages, the study was still
published. Thus, from a methodological point of view,
the purpose of this study was to investigate whether
PCA-based unsupervised FE could identify slight differ-
ences; thus it is a new challenge for this methodology.
Methods
Gene expression and promoter methylation profiles
Gene expression/promoter methylation profiles were
retrieved from the gene expression omnibus (GEO) using
GEO ID GSE59511. This super series consists of two sub-
series, GSE43559 and GSE59510, each of which includes
gene expression (using Affymetrix Rat Gene 1.0 ST Array)
and promoter methylation (using NimbleGen Rat CpG
Island Plus RefSeq Promoter 720k array) information,
respectively. Gene expression profiles were directly loaded
from GEO to R [18] by getGEO function while six files
whose names ended with ratio_peaks_mapToFeature-
s_All_Peaks.txt.gz were downloaded and loaded into R
using read.csv for promoter methylation. Table 1 shows a
list of the samples analyzed. GSE43559 (gene expression)
consists of eight samples classified into four categories,
E13 control, E13 treated, E16 control, and E16 treated.
GSE59510 (promoter methylation) consists of six samples
classified into two categories, E13 and E16 (all from F3
generation primordial germ lines). Using the ratio between
treated and control groups, eight gene expression profiles






















The reason we used a ratio of control to treated
instead of the usual ratio of treated to control is
explained in additional file 1. These were further nor-
malized to have a mean of zero and a variance of one
within each sample. Because six samples in GSE59510
were already transformed to a ratio between treated/
control samples, these were not normalized. In total,
14 (8+6) samples that exhibited a ratio between control/
treated samples were pooled and prepared for further
analyses. The only difference between control and trea-
ted samples was whether oil or vinclozolin was injected
to F1 pregnant rats between E8 and E14. Any other
treatments were identical between E13 and E16.
Principal component analysis-based unsupervised feature
extraction
Although this method was described in detail in a
recently published review article [19], this methodology
is briefly introduced here. Example: xij is the gene
expression/promoter methylation of the ith gene
(i = 1, ..., N) in the jth sample (j = 1, ..., M). For sim-
plicity, it is assumed that the mean of xij over i within
each j is zero. Then, in contrast to the ordinary usage
of PCA where samples are embedded into the low
dimensional space, genes are embedded into the low
dimensional space by applying PCA. Thus, principal
component (PC) scores of the ℓth component, xiℓ, (ℓ =
1, ..., M) are attributed to each gene while each sample
has contributed cℓj to the ℓth component. By this defi-





PCA-based unsupervised FE attempts to extract fea-
tures (in this specific application, genes) with larger
absolute PC scores along the specified ℓth PC.




GSM1065332 PGC E13 F3-Control biological rep1
GSM1065333 PGC E13 F3-Control biological rep2
GSM1065334 PGC E13 F3-Vinclozolin biological rep1
GSM1065335 PGC E13 F3-Vinclozolin biological rep2
GSM1065336 PGC E16 F3-Control biological rep1
GSM1065337 PGC E16 F3-Control biological rep2
GSM1065338 PGC E16 F3-Vinclozolin biological rep1
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In the specific application described in the present
study, N′expression probes using gene expression and
N′methylation probes using promoter methylation were
selected, respectively. For the computation of P-values





Although there are several ways to determine which PC
is employed for FE, the most straightforward and intui-
tive strategy is to identify PCs that are mostly coincident
with categories by employing categorical regression:




where aℓ and akℓ are numerical (regression) coeffi-
cients. Then, the ℓth PC associated with the (most) sig-
nificant regression is employed as the PC for FE.
Because this study only contained two categories (E13
and E16), we used the t test instead of categorical
regression to measure the significance of coincidence
between cℓj and categories.
t test-based FE
The t test was applied to gene expression/promoter
















































were compared. Then the most sig-
nificant (i.e., associated with smaller P-values) N′expression
and N′methylation probes were selected, respectively. For
the computation of P-values of coincident analysis with






limma [20] was applied to gene expression and promo-
ter methylation as follows. For gene expression, after
converting raw gene expression to logarithmic values,
the model Diff = (E16.VIN-E16.CNTL)-(E13.VIN-E16.
CNTL) was applied, where VIN and CNTL correspond
to treated and control samples, respectively. For promo-
ter methylation, only the ratio between control and trea-
ted samples was provided (see Table 1), and the two
class model was applied for E13 and E16 samples (R
source codes are shown in additional file 1). Then the
obtained P-values were employed for FE. The remaining
procedures were the same as for the previous two FEs.
SAM-based FE
SAM [21] was applied to gene expression and promoter
methylation separately, as shown in Table 1, i.e., as two
class problems of E13 and E16 (siggenes packages [22]
in Bioconductor [23] was used). Then, the obtained
P-values were used for FE. The remaining procedures
were the same as for the previous three FEs.
Protein-protein interaction enrichment analysis
The obtained RefSeq mRNA IDs were converted to gene
names ("official gene symbol”) via a gene ID conversion
tool implemented in DAVID [24], and the obtained gene
names were uploaded to STRING [25] server. Then,
“protein-protein interactions” was selected among the
pull-down menu of “enrichment”, where the expected
number of PPIs for the set of genes uploaded and the P-
value attributed to identified PPIs are available.
Gene ID identification for literature searches
Literature searches were performed using gene symbols
that were converted from RefSeq mRNAs using DAVID
as explained above.
Results and Discussion
Gene selection using PCA-based unsupervised FE
Figure 1 illustrates the strategy to identify aberrant gene
expression associated with aberrant promoter methyla-
tion between controls and vinclozolin treated samples
during development from E13 to E16. Gene expression
and promoter methylation of vinclozolin treated F3
samples were normalized relative to controls. Then, by
separately applying PCA-based unsupervised FE to each
sample group, the top N’ (≪ N) genes were indepen-
dently selected. The number of commonly selected
genes N’’ was counted. If N’’ was much larger than
expected, the selection of aberrant gene expression asso-
ciated with aberrant promoter methylation was deter-
mined to be successful.
At first, the PCs used for FE shown in Figure 1 were
specified and a boxplot (PC2 for mRNA and PC1 for
Taguchi BMC Bioinformatics 2015, 16(Suppl 18):S16
http://www.biomedcentral.com/1471-2105/16/S18/S16
Page 4 of 13
methylation) is shown in Figure 2. These two PCs
exhibited a significant distinction between the two cate-
gories, E13 and E16. Using the specified PCs, PCA-
based unsupervised FE was performed. Then, the most
significant N’ genes were extracted for gene expression
and promoter methylation, respectively. P-values to
determine whether the coincidence and the number of
commonly selected genes among N’ genes occurred
accidentally was computed by binomial distribution.
How the P-values varied dependent upon N’ was deter-
mined. Figure 3 shows the dependence of P-values upon
N’ when N = 13324, the number of genes commonly
included in gene expression and promoter methylation
profiles. P-values were smaller for larger N’. However,
the minimum N’ with P-values less than 0.05 were
selected (i.e., N’ = 1000) to minimize the number of
genes selected to reduce the time spent performing lit-
erature searches in the later part of this study. Among
the 1000 genes selected in either gene expression or
promoter methylation, 48 RefSeq mRNAs were com-
monly selected (a list of gene names and boxplots of
individual genes are shown in additional files 2 and 3).
The P-value for N’ = 1000 was 0.04 (see Figure 3, and
this value was confirmed by the shuffle test, additional
file 1). Thus, we successfully selected genes that were
significantly associated with simultaneous aberrant gene
expression/promoter methylation.
To biologically validate these 48 RefSeq mRNAs, we
uploaded them to three enrichment analyses servers,
DAVID [24], TargetMine [26] and g:Profiler [27]. We
observed some biological terms were enriched among
the selected genes (Table 2). Almost 50% of the genes
selected belonged to G-protein coupled receptors
(GPCR) or cell surface receptor pathways, which was
expected because an endocrine disruptor such as vinclo-
zolin targets cell surface receptors. We also estimated
PPI enrichment (see methods). Because it is rare for
proteins to function in the absence of collaboration with
other proteins, enriched PPIs among the selected genes
(proteins) can provide supporting evidence for the biolo-
gical significance of selected genes. There were seven
PPIs although the expected number of PPIs was three.
This resulted in P = 0.05; thus there was significant PPI
Figure 1 Schematics that illustrate the procedure of PCA-based
unsupervised FE applied to data set analyzed in the present study.
Figure 2 Boxplots of PCs used for FE in this study, PC2 for
mRNA and PC1 for methylation. P-values are computed by t test.
Figure 3 Dependence of logarithmic P-values that represent
the significance of commonly selected genes between gene
expression and promoter methylation upon N’ when PCA-
based unsupervised FE was employed. Horizontal broken red line
represents P = 0.05.
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enrichment among the genes selected by PCA-based
unsupervised FE.
P-values shown in Figure 3 remained significant even
when N’ increased from 1000 to 2000. Thus, we tried
to obtain more genes by setting N’ = 2000, because the
greater number of genes uploaded would have a ten-
dency to enhance enrichment. There were 179 mRNAs
commonly selected between gene expression and pro-
moter methylation (see additional file 3 for the full
list). Uploading these genes to three enrichment ana-
lyses servers resulted in greater enrichment for these
179 genes as expected (Tables 3, 4, and 5).
GPCR and cell surface receptors were enhanced and
olfactory transduction related biological terms were vastly
Table 2. Enrichment analysis of 48 RefSeq mRNAs commonly selected in the top most 1000 genes by applying PCA-
based unsupervised FE to gene expression and promoter methylation
DAVID
GO BP
GO:0007186 19 G-protein coupled receptor protein signaling pathway 5.35E-03
GO:0007166 21 Cell surface receptor linked signal transduction 4.19E-03
g:proflier
GO BP
GO:0003008 17 System process 4.37E-02
GO:0007166 22 Cell surface receptor signaling pathway 8.91E-03
GO MF
GO:0060089 17 Molecular transducer activity 4.49E-02
GO:0004871 17 Signal transducer activity 1.82E-02
GO:0004872 17 Receptor activity 1.13E-02
GO:0038023 17 Signaling receptor activity 3.98E-03
GO:0004888 16 Transmembrane signaling receptor activity 1.08E-02
GO:0004930 14 G-protein coupled receptor activity 4.43E-02
Table 3. Enrichment analysis of 179 genes commonly selected in the top most 2000 genes by applying PCA-based
unsupervised FE to gene expression and promoter methylation
DAVID
KEGG
rno04740 50 Olfactory transduction 1.63E-15
GO BP
GO:0007186 79 G-protein coupled receptor protein signaling pathway 2.04E-20
GO:0007166 85 Cell surface receptor linked signal transduction 2.39E-18
GO:0050911 59 Detection of chemical stimulus involved in sensory perception of smell 1.99E-18
GO:0050907 59 Detection of chemical stimulus involved in sensory perception 2.22E-18
GO:0009593 59 Detection of chemical stimulus 3.09E-18
GO:0007608 59 Sensory perception of smell 3.38E-18
GO:0050906 59 Detection of stimulus involved in sensory perception 3.26E-18
GO:0007606 60 Sensory perception of chemical stimulus 2.89E-18
GO:0051606 60 Detection of stimulus 2.88E-18
GO:0007600 61 Sensory perception 3.31E-16
GO:0050890 62 Cognition 2.44E-15
GO:0050877 62 Neurological system process 1.94E-12
GO CC
GO:0016021 101 Integral to membrane 3.57E-12
GO:0031224 101 Intrinsic to membrane 1.65E-11
GO:0031983 7 Vesicle lumen 1.49E-03
GO:0060205 6 Cytoplasmic membrane-bounded vesicle lumen 7.41E-03
GO:0031091 6 Platelet alpha granule 1.59E-02
GO:0031093 5 Platelet alpha granule lumen 3.82E-02
GO MF
GO:0004984 60 Olfactory receptor activity 1.59E-19
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enriched. Careful investigation of the selected genes indi-
cated that many olfactory receptor proteins were newly
identified when N’ was increased from 1000 to 2000. Olfac-
tory receptor proteins were also recognized by Skinner et al
[6]. Thus, the identification of many olfactory receptor pro-
teins suggested the correctness and superiority of our
methodology, because Skinner et al [6] did not identify reci-
procal relationships between gene expression and promoter
Table 4. Enrichment analysis of 179 genes commonly selected in the top most 2000 genes by applying PCA-based
unsupervised FE to gene expression and promoter methylation
g:profiler GO BP
GO:0007606 54 Sensory perception of chemical stimulus 9.14E-21
GO:0007186 65 G-protein coupled receptor signaling pathway 7.61E-20
GO:0050911 50 Detection of chemical stimulus involved in sensory perception of smell 1.44E-19
GO:0007600 58 Sensory perception 2.89E-19
GO:0050907 50 Detection of chemical stimulus involved in sensory perception 5.26E-19
GO:0007608 50 Sensory perception of smell 5.65E-19
GO:0009593 50 Detection of chemical stimulus 1.72E-18
GO:0050906 50 Detection of stimulus involved in sensory perception 3.39E-18
GO:0007166 84 Cell surface receptor signaling pathway 4.19E-18
GO:0003008 69 System process 8.92E-18
GO:0051606 51 Detection of stimulus 1.26E-17
GO:0050877 59 Neurological system process 3.82E-16
GO:0051716 106 Cellular response to stimulus 6.09E-13
GO:0042221 84 Response to chemical 9.54E-13
GO:0050896 116 Response to stimulus 4.65E-12
GO:0007154 98 Cell communication 4.91E-12
GO:0007165 92 Signal transduction 2.84E-11
GO:0044700 95 Single organism signaling 6.05E-11
GO:0023052 95 Signaling 6.70E-11
GO:0065007 131 Biological regulation 3.40E-10
GO:0050789 128 Regulation of biological process 3.48E-10
GO:0050794 120 Regulation of cellular process 1.92E-07
GO:0044707 94 Single-multicellular organism process 9.54E-07
GO:0032501 94 Multicellular organismal process 8.75E-06
GO:0044763 129 Single-organism cellular process 1.17E-05
GO:0044699 135 Single-organism process 1.86E-04
GO:0046010 3 Positive regulation of circadian sleep/wake cycle, non-REM sleep 2.21E-02
GO CC
GO:0016021 88 Integral component of membrane 1.13E-12
GO:0031224 88 Intrinsic component of membrane 3.85E-12
GO:0071944 79 Cell periphery 1.19E-08
GO:0044425 92 Membrane part 1.43E-08
GO:0005886 77 Plasma membrane 3.24E-08
GO:0016020 97 Membrane 1.09E-02
GO MF
GO:0038023 70 Signaling receptor activity 5.11E-023
GO:0004930 64 G-protein coupled receptor activity 5.42E-023
GO:0004888 68 Transmembrane signaling receptor activity 1.3E-022
GO:0004871 72 Signal transducer activity 1E-021
GO:0004872 70 Receptor activity 4.63E-021
GO:0060089 72 Molecular transducer activity 5.95E-020
GO:0004984 50 Olfactory receptor activity 1.39E-019
KEGG
KEGG:04740 42 Olfactory transduction 6.46E-014
KEGG:05144 5 Malaria 1.96E-02
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methylation, probably owing to a lack of suitable statistical
methods, although they noted their importance.
PPI enrichment significance was also enhanced when N’
increased from 1000 to 2000. There were 360 PPIs among
179 genes while the expected number of PPIs was 191.
This resulted in P = 0 (within the numerical accuracy
adopted); thus the significance of PPI enrichment was
enhanced. The increase of PPIs was mostly due to the
newly identified olfactory receptor proteins.
These data suggest the biological suitability of our
methodology.
Comparisons with other supervised FEs
Although PCA-based unsupervised FE was already
demonstrated to perform better than various conven-
tional methods reported for various applications [8-17],
other simpler methods might achieve a comparative per-
formance in this specific example, although the study by
Skinner et al [6] was unsuccessful. To demonstrate the
superiority of PCA-based unsupervised FE compared
with a simpler method, genes were selected by t test
between E13 and E16. The t test was applied to the F3
generation vinclozolin lineage gene expression/promoter
Table 5. Enrichment analysis of 179 genes commonly selected in the top most 2000 genes by applying PCA-based
unsupervised FE to gene expression and promoter methylation
TargetMine GO BP
GO:0007600 43 Sensory perception 5.81E-12
GO:0007606 40 Sensory perception of chemical stimulus 8.20E-12
GO:0050907 38 Detection of chemical stimulus involved in sensory perception 2.64E-11
GO:0051606 39 Detection of stimulus 2.64E-11
GO:0009593 38 Detection of chemical stimulus 3.56E-11
GO:0050906 38 Detection of stimulus involved in sensory perception 3.60E-11
GO:0003008 48 System process 3.93E-11
GO:0050877 43 Neurological system process 5.27E-11
GO:0007186 41 G-protein coupled receptor signaling pathway 3.63E-09
GO:0007166 46 Cell surface receptor signaling pathway 2.01E-06
GO:0042221 59 Response to chemical 3.63E-06
GO:0044707 60 Single-multicellular organism process 3.94E-05
GO:0032501 61 Multicellular organismal process 6.44E-05
GO:0050911 24 Detection of chemical stimulus involved in sensory perception of smell 9.90E-05
GO:0007608 24 Sensory perception of smell 1.24E-04
GO:0051716 59 Cellular response to stimulus 1.04E-03
GO:0007165 49 Signal transduction 1.30E-03
GO:0050896 68 Response to stimulus 2.64E-03
GO:0065007 75 Biological regulation 4.11E-03
GO:0007154 52 Cell communication 4.97E-03
GO:0050789 71 Regulation of biological process 1.07E-02
GO:0023052 49 Signaling 2.56E-02
GO:0044700 49 Single organism signaling 2.56E-02
GO:0044699 84 Single-organism process 4.23E-02
GO CC
GO:0016021 46 Integral component of membrane 8.14E-07
GO:0031224 46 Intrinsic component of membrane 9.96E-07
GO:0044425 51 Membrane part 3.43E-04
GO:0016020 56 Membrane 2.37E-02
GO MF
GO:0004871 45 Signal transducer activity 5.80E-10
GO:0004888 43 Transmembrane signaling receptor activity 5.80E-10
GO:0038023 44 Signaling receptor activity 5.80E-10
GO:0004872 44 Receptor activity 7.10E-10
GO:0060089 45 Molecular transducer activity 7.10E-10
GO:0004984 24 Olfactory receptor activity 8.31E-05
KEGG
rno04740 50 Olfactory transduction 1.05E-13
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methylation and normalized to control samples (see
methods) and the most N’ significant genes were selected
for both gene expression and promoter methylation.
Then the significance of overlap between genes selected
by the t test related to gene expression and promoter
methylation was determined. Results demonstrated that
in the range of N’ ≤ 2000, the minimum achieved P was
0.38, which was not significant (additional file 4).
P-values increased as N’ approached 2000 in contrast to
the tendency seen in Figure 3 and there were no overlaps
when N’ ≤ 300; thus, the P-value could not be computed.
Therefore, in this specific example, PCA-based unsuper-
vised FE achieved a good performance compared with a
simpler method. The second method we compared was
limma [20] (see Methods), a popular method used for
gene expression analyses, especially when genes exhibit
differential expression between multiple conditions. In
the first page of the manual, limma was identified as aim-
ing to analyze a small number of samples; “Empirical
Bayesian methods are used to provide stable results even
when the number of arrays is small”. Thus, limma is a
very suitable method whose performance should be com-
pared with PCA based unsupervised FE that also aims to
treat small sample cases. The results were disappointing.
Within the range of N’ ≤ 2000, there were only two N’
associated with P-values less than 0.05, when N’s tested
were taken to be equivalent to those when PCA-based
unsupervised FE as well as t test-based FE were employed
(additional file 4). The number of genes selected com-
monly between gene expression and promoter methyla-
tion was also small. When N’ = 800 such that there were
as many common genes as possible, the number of genes
commonly selected between gene expression and promo-
ter methylation was 33 Refseq mRNAs, among which
there were no overlaps with the 48 RefSeq mRNAs
selected by PCA-based unsupervised FE when N’ = 1000
(the list of 33 RefSeq mRNAs identified by limma-based
FE is shown in additional file 3). Furthermore, biological
validation was also disappointing. Even uploading these
33 RefSeq mRNAs to three enrichment servers, the iden-
tified enrichments were zero. DAVID, g:Profiler or Tar-
getMine identified no enriched GO BP, CC, MF terms or
KEGG pathways. There were also no PPIs detected by
STRING among the RefSeq mRNAs genes. Moreover,
because there are no larger N’ associated with P-values
less than 0.05, we could not increase the number of com-
mon genes such that more enrichments were detected.
The third method we compared was SAM [21] (see
Methods), another popular method used for gene expres-
sion analyses, also designed for multiclass problems. The
results were again disappointing. Within the range of N’
≤ 2000, there were only four N’ associated with P-values
less than 0.05, when N′s tested were taken to be equiva-
lent to those when the other three methods were
employed (additional file 4). The number of genes
selected commonly between gene expression and promo-
ter methylation was also small. When N’ = 800 such that
there were as many common genes as possible, the num-
ber of genes commonly selected between gene expression
and promoter methylation was 30 RefSeq mRNAs (the
list of 30 RefSeq mRNAs identified by SAM-based FE is
shown in additional file 3), among which there were 11
RefSeq mRNAs that were also included in the 48 RefSeq
mRNAs identified by PCA-based unsupervised FE when
N’ = 1000. Furthermore, biological validation was also
disappointing. No GO BP, CC, MF terms or KEGG path-
way enrichments were identified when these 30 RefSeq
mRNAs were uploaded to the DAVID, g:Profiler or Tar-
getMine enrichment servers. There were also only two
PPIs (P = 0.37, thus not significant) detected by STRING
among the RefSeq mRNAs genes. Moreover as for
limma, because there are no larger N’ associated with
P-values less than 0.05, we could not increase the num-
ber of common genes such that more enrichments were
detected.
Thus, we conclude that PCA-based unsupervised FE
outperformed simple t test-based FE, the sophisticated
Bayesian methodology (limma)-based FE, and the popular
SAM-based FE. Therefore, the superiority of PCA-based
unsupervised FE to these methods was demonstrated.
Biological significance of selected genes: literature
searches
To estimate the biological significance of the selected 48
RefSeq mRNAs selected by PCA-based unsupervised FE
when N’ = 1000 in more detail, we performed a litera-
ture search for each gene selected. During the searches,
we focused on the relationship between selected genes
and diseases; Anway et al [5] reported that TGE induced
by vinclozolin caused tumor, prostate, kidney, testis and
immune diseases. Table 6 summarizes the association of
selected genes previously reported to be related to
tumor, prostate, kidney, testis and immune disease. Of
the 48 RefSeq mRNAs identified, 22 were associated
with targeted properties (the list of references identified
by literature searches as well as detailed discussions are
available in additional file 1). This indicates the success
of our methodology to identify genes potentially asso-
ciated with causing TGE mediated diseases in the F3
generation vinclozolin lineage.
To further compare genes selected by PCA-based
unsupervised FE with those selected by limma and SAM
from a biological point of view, we also performed lit-
erature searches of the 33 RefSeq mRNAs selected by
limma (Table 7) and 19 RefSeq mRNAs selected by
SAM but not included in the 48 Refseq mRNAs identi-
fied by PCA-based unsupervised FE when N’ = 1000
(Table 8). The list of references identified by literature
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searches is shown in additional file 1. The limma-based
FE was inferior to PCA-based unsupervised FE because
only 13 genes were identified by the literature search
and were reported to be related to lower numbers of
terms including “tumors”, “prostate”, “kidney”, “testis”
and “immune”. On the other hand, the SAM-based FE
showed more promising results, which was expected
because it identified 11 RefSeq mRNAs that overlapped
with 48 RefSeq mRNAs identified by PCA-based unsu-
pervised FE when N’ = 1000. In Table 8, 11 out of 19
genes were associated with disease. Therefore, it might
be thought that SAM-based FE was superior to PCA-
based unsupervised FE, which only identified 22 disease
associated genes among 48 genes. However, PCA-based
unsupervised FE also identified 179 genes by increasing
N’ from 1000 to 2000, which is impossible for SAM-
based FE. We found that only three genes (IL15,
PGAM2, and ZFP36L1) that were not included in the
179 RefSeq mRNAs identified by PCA-based unsuper-
vised FE when N’ = 2000. This suggested that PCA-
based unsupervised FE identified almost the same genes
as cover those identified by SAM-based FE. Although the
disease associations of genes identified by PCA-based
unsupervised FE and previously reported in the literature
might not have been confirmed or remain just an obser-
vation or hypothesis, the strict difference in disease asso-
ciated genes identified by PCA-based unsupervised FE
and those by other methods suggested the superiority of
PCAbased unsupervised FE.
Thus, PCA-based unsupervised FE appeared superior
to limma and SAM-based FE.
Two groups of selected genes: chemokine signaling
pathway genes and LRR proteins
To provide further insights of the genes selected by PCA-
based unsupervised FE when N’ = 1000, we focused on
two categories: chemokine signaling pathway genes and
LRR proteins, both of which have been extensively
reported to be related to vinclozolin mediated diseases.
Table 6. Summary of literature searches for genes
selected by PCA-based unsupervised FE when N’ = 1000
Gene Tumors Prostate Kidney Testis Immune
Disease
CCR2 ○ ○ ○ ○
LRRN3 ○ ○
AHR ○ ○ ○ ○ ○
LOX ○ ○ ○ ○ ○
PRAMEL1 ○ ○ ○
CD53 ○ ○ ○




PF4 (CXCL4) ○ ○ ○ ○
PDHA2 ○
MPO ○ ○ ○ ○ ○
HAND2 ○




DBH ○ ○ ○ ○ ○
KCNT1 ○
FGB ○ ○ ○ ○
BMP3 ○ ○ ○
ACTG2 ○
AQP2 ○ ○ ○
Circles indicate that there was at least one study reporting a relationship
between identified gene and disease. For related references, see additional
file 1. Genes that were reported to be related to tumor, prostate, kidney, testis
and immune diseases are listed.
Table 7. Summary of literature searches for genes
selected by limma-based FE
Gene Tumors Prostate Kidney Testis Immune Disease











XRCC1 ○ ○ ○ ○
Circles indicate that there was at least one study reporting a relationship. For
related references, see additional file 1. Genes that were reported to be
related to tumor, prostate, kidney, testis and immune diseases are listed.
Table 8. Summary of literature searches for genes
selected by SAM-based FE, but not by PCA-based
unsupervised FE when N’ = 1000




Alb ○ ○ ○ ○ ○
SLC13A3 ○ ○ ○
TTR ○ ○ ○ ○ ○
ANGPTL1 ○
TUBB3 ○ ○ ○ ○
IL15 ○ ○ ○ ○ ○
BATCh1 ○ ○ ○
ZFP36L1 ○ ○
Circles indicate that there was at least one study reporting a relationship. For
related references, see additional file 1. Genes that were reported to be
related to tumor, prostate, kidney, testis and immune diseases are listed.
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This also supports the effectiveness of our methodology
and the importance of the selected genes.
Chemokine signaling pathway
Four chemokine/chemokine receptors were selected:
CCR2, PF4 (CXCL4), CCL3, and CMKLR1. The first
three belong to the chemokine signaling pathway
(rno04062) in KEGG, as either ligands or receptors that
activate chemokine signaling pathways. In addition,
CMKLR1 is a chemokine receptor-like protein although
it is not included in the KEGG pathway. They are all
localized at cell surfaces, and therefore are expected to
function together to activate/inactivate chemokine signal-
ing pathways. It is reasonable that they are detected
together in the present analysis. Some studies also sug-
gested a relationship between chemokines and vinclozo-
lin. Cowin et al [28] reported that prostatic inflammation
was associated with the postpubertal activation of proin-
flammatory NFB-dependent genes, including the che-
mokine IL-8 when embryos were exposed to vinclozolin
in rats. Chemokine signaling pathways were associated
with genes whose expression was altered in rat F3 gen-
eration vinclozolin lineage Sertoli cells [2]. The expres-
sion of Cxcr4 and Cxcl2 was altered in vinclozolin F3
generation rat prostate epithelial cells [28]. Interestingly,
together with Cxcr4 and Cxcl2, BMP6 was reported to
have an altered expression [28]. BMP6 shares binding
specificity with BMP3, which was also identified in this
study (see Table 6). BMP proteins belong to the TGFb
pathway (rno04350) that is grouped with the chemokine
signaling pathway as part of the cytokine-cytokine recep-
tor interaction system (rno04060). Furthermore, numer-
ous studies have suggested a relationship between
chemokine signaling pathways and various diseases. For
example, the inhibition of chemokine-induced biological
activity is a promising therapeutic strategy for proteinuric
disorders [29]. Chemokines and chemokine receptors
play critical roles in prostate cancer development and
progression [30] as well as in testicular inflammation
[31]. Thus, TGE abnormalities caused by vinclozolin
might develop through the regulation of inherited pro-
moter methylation during the stages of development, by
affecting chemokine signaling pathways.
LRR proteins
LRRN3, PRAMEL1, and LRRTM1 are LRR proteins
shown in Table 6 or in additional files 2 and 3. LRR
proteins were frequently reported to be associated with
F3 generation vinclozolin lineages, e.g., LRRc48,
LRRc56, and LRRc8B [2], LR-RTM3 and ELFN2 [3],
Lrfn3 [28], Lrrc46, Lrrc48, Lgi2, Fbxl7, Lgi4, Lrig1,
Fbxl12, Lrfn1, Lingo1, Lrrc8b, Lrrn2, and LRRTM1.
Lrrtm4 [4], Lrrc61 [32], and Lrrc56 [6] were reported to
be related to F3 generation vinclozolin lineages.
Although the frequent observation of aberrant LRR pro-
tein expression in F3 generation vinclozolin lineages
does not always indicate that LRR proteins are potential
causative factors of vinclozolin mediated transgenera-
tional epigenetic-induced diseases, there are multiple
reports that suggest a relationship between LRR proteins
and nervous system disorders. LRRTM1, LRRTM3,
LRRN1 and LRRN3 were reported to be related to aut-
ism spectrum disorder [33] and polymorphisms in LRR
genes are associated with autism spectrum disorder sus-
ceptibility in populations of European ancestry [33].
Deletions in the LRRTM binding partner neurexin 1
(NRXN1) have also been linked to schizophrenia [34].
Moreover, LRR protein dysfunction may disrupt neuro-
nal excitation/inhibition balance and contribute to neu-
ropsychiatric disorders [35,36]. LRRTM3 was also
identified as a candidate gene for late-onset Alzheimer’s
disease [37]. Toll-like receptors, transmembrane
LRR proteins that bind a wide molecular variety of
pathogen-associated ligands and are involved in immune
responses and have been implicated in neurodegenera-
tive diseases such as multiple sclerosis, stroke, and
Alzheimer’s disease [38,39]. Moreover, LRR proteins are
generally believed to play critical roles in the develop-
ment of neural circuits [35,36]; e.g., LRRTMs and neu-
roligins bind neurexins differentially to cooperate in
glutamate synapse development [40]. Although neuroli-
gins and neurexins mediate connections between pre/
post-synapses [41], LRR proteins co-function with neu-
roligins and neurexins [36]. However, there are multiple
reports that suggest vinclozolin mediates nervous system
disorders. For example, the exposure of rats to vinclozo-
lin increased risk for autism [7]. Furthermore, perinatal
exposure to endocrine disruptors was generally asso-
ciated with autism spectrum disorder [42] and exposure
to vinclozolin significantly increased vulnerability to
anxiety [43]. Thus, this association was suggested to be
heritable [44]. Therefore, it is not surprising that LRR
proteins cause vinclozolin mediated neuropsychiatric
disorders including autism spectrum disorder.
Conclusions
This study re-analyzed the gene expression/promoter
methylation profiles of primordial germ cells between
E13 and E16 rat F3 generation vinclozolin lineage [6]. In
contrast to analyses performed previously [6], we suc-
cessfully identified various genes associated with aberrant
promoter methylation/gene expression using treated and
control samples. Identified genes were related to pre-
viously reported diseases in F3 generation vinclozolin
lineage. We focused on two categories, chemokine signal-
ing pathway molecules and LRR proteins, that might be
disease causing factors. The success of the study metho-
dology suggests the possibility that abnormalities in F3
generation vinclozolin lineage are mediated by heritable
Taguchi BMC Bioinformatics 2015, 16(Suppl 18):S16
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aberrant promoter methylation during development
between generations.
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